Inhibitori angiogeneze (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitori angiogeneze" in Serbian language version.

refsWebsite

Global rank Serbian rank

10doi.org

2^nd place

4^th place

7nih.gov

4^th place

8^th place

2semanticscholar.org

11^th place

23^rd place

2web.archive.org

1^st place

1cancer.gov

1,684^th place

703^rd place

1ceon.rs

low place

228^th place

1mcgraw-hill.com

low place

288^th place

1drugsafetysite.com

low place

1oxfordjournals.org

1,389^th place

438^th place

1acs.org

1,248^th place

389^th place

1aacrjournals.org

8,869^th place

8,510^th place

aacrjournals.org

mct.aacrjournals.org

Daekyu Sun. „The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents”. Mol Cancer Ther April. 2008 (7): 880. doi:10.1158/1535-7163.MCT-07-2119.

acs.org

pubs.acs.org

Himesh Fernando; Anthony P. Reszka; Julian Huppert; Sylvain Ladame; Sarah Rankin; Ashok R. Venkitaraman; Stephen Neidle & Shankar Balasubramanian (2006). „A Conserved Quadruplex Motif Located in a Transcription Activation Site of the Human c-kit Oncogene”. Biochemistry. 45 (25): 7854—7860. doi:10.1021/bi0601510.

cancer.gov

Cancer.com [homepage on the Internet]. National Cancer Institute at the National Institutes of Health; 2011 [cited 18 March 2014]. Available from: „Angiogenesis Inhibitors - NCI”. мај 2018. Архивирано из оригинала 08. 02. 2015. г. Приступљено 26. 10. 2018.

ceon.rs

scindeks-clanci.ceon.rs

Vučević, D., Radak, Đ., Milovanović, I., Radosavljević, T., & Mladenović, D. [2013]. Patofiziološki mehanizmi angiogeneze u aterogenezi. Medicinski pregled, 66(7-8), 297-306.

doi.org

Hayden, Erika Check (2009). „Cutting off cancer's supply lines”. Nature. 458 (7239): 686—687. PMID 19360048. S2CID 29940580. doi:10.1038/458686b.
Ng EW, Adamis AP (01. 06. 2005). „Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration”. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie. 40 (3): 352—68. PMID 15947805. doi:10.1016/S0008-4182(05)80078-X. Непознати параметар |name-list-style= игнорисан (помоћ)
Los M, Roodhart JM, Voest EE (2007). „Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer”. The Oncologist. 12 (4): 443—50. PMID 17470687. doi:10.1634/theoncologist.12-4-443.
BláZquez, Cristina; GonzáLez-Feria, Luis; áLvarez, Luis; Haro, Amador; Casanova, M. Llanos; Guzmán, Manuel (2004). „Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas”. Cancer Research. 64 (16): 5617—5623. PMID 15313899. S2CID 1357974. doi:10.1158/0008-5472.CAN-03-3927.
Adis RD (2002). „Bevacizumab. Anti-VEGF monoclonal antibody, avastin, rhumab-VEGF”. Drugs R&D. 3 (1): 28—30. PMID 11881526. doi:10.2165/00126839-200203010-00006.
Jeganathan VS, Verma N. (2009). „Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration”. Curr. Opin. Ophthalmol. 20 (3): 223—225. PMID 19367163. doi:10.1097/ICU.0b013e328329b656.
Tolentino M. (2011). „Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease”. Surv. Ophthalmol. 56 (2): 95—113. PMID 21335144. doi:10.1016/j.survophthal.2010.08.006.
Daekyu Sun. „Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents”. Nucleic Acids Research. 33 (18): 6070—6080. doi:10.1093/nar/gki917.
Himesh Fernando; Anthony P. Reszka; Julian Huppert; Sylvain Ladame; Sarah Rankin; Ashok R. Venkitaraman; Stephen Neidle & Shankar Balasubramanian (2006). „A Conserved Quadruplex Motif Located in a Transcription Activation Site of the Human c-kit Oncogene”. Biochemistry. 45 (25): 7854—7860. doi:10.1021/bi0601510.
Daekyu Sun. „The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents”. Mol Cancer Ther April. 2008 (7): 880. doi:10.1158/1535-7163.MCT-07-2119.

drugsafetysite.com

„Thalidomide: Drug safety during pregnancy and breastfeeding / DRUGSAFETYSITE.COM”. Архивирано из оригинала 05. 12. 2013. г. Приступљено 29. 10. 2018.

mcgraw-hill.com

books.mcgraw-hill.com

Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). „IV. Miscellaneous agents; Thalidomide”. Goodman & Gilman's The Pharmacological Basis of Therapeutics (11. изд.). New York: McGraw-Hill. ISBN 0071422803.

nih.gov

ncbi.nlm.nih.gov

Hayden, Erika Check (2009). „Cutting off cancer's supply lines”. Nature. 458 (7239): 686—687. PMID 19360048. S2CID 29940580. doi:10.1038/458686b.
Ng EW, Adamis AP (01. 06. 2005). „Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration”. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie. 40 (3): 352—68. PMID 15947805. doi:10.1016/S0008-4182(05)80078-X. Непознати параметар |name-list-style= игнорисан (помоћ)
Los M, Roodhart JM, Voest EE (2007). „Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer”. The Oncologist. 12 (4): 443—50. PMID 17470687. doi:10.1634/theoncologist.12-4-443.
BláZquez, Cristina; GonzáLez-Feria, Luis; áLvarez, Luis; Haro, Amador; Casanova, M. Llanos; Guzmán, Manuel (2004). „Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas”. Cancer Research. 64 (16): 5617—5623. PMID 15313899. S2CID 1357974. doi:10.1158/0008-5472.CAN-03-3927.
Adis RD (2002). „Bevacizumab. Anti-VEGF monoclonal antibody, avastin, rhumab-VEGF”. Drugs R&D. 3 (1): 28—30. PMID 11881526. doi:10.2165/00126839-200203010-00006.
Jeganathan VS, Verma N. (2009). „Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration”. Curr. Opin. Ophthalmol. 20 (3): 223—225. PMID 19367163. doi:10.1097/ICU.0b013e328329b656.
Tolentino M. (2011). „Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease”. Surv. Ophthalmol. 56 (2): 95—113. PMID 21335144. doi:10.1016/j.survophthal.2010.08.006.

oxfordjournals.org

nar.oxfordjournals.org

Daekyu Sun. „Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents”. Nucleic Acids Research. 33 (18): 6070—6080. doi:10.1093/nar/gki917.

semanticscholar.org

api.semanticscholar.org

Hayden, Erika Check (2009). „Cutting off cancer's supply lines”. Nature. 458 (7239): 686—687. PMID 19360048. S2CID 29940580. doi:10.1038/458686b.
BláZquez, Cristina; GonzáLez-Feria, Luis; áLvarez, Luis; Haro, Amador; Casanova, M. Llanos; Guzmán, Manuel (2004). „Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas”. Cancer Research. 64 (16): 5617—5623. PMID 15313899. S2CID 1357974. doi:10.1158/0008-5472.CAN-03-3927.

web.archive.org

Cancer.com [homepage on the Internet]. National Cancer Institute at the National Institutes of Health; 2011 [cited 18 March 2014]. Available from: „Angiogenesis Inhibitors - NCI”. мај 2018. Архивирано из оригинала 08. 02. 2015. г. Приступљено 26. 10. 2018.
„Thalidomide: Drug safety during pregnancy and breastfeeding / DRUGSAFETYSITE.COM”. Архивирано из оригинала 05. 12. 2013. г. Приступљено 29. 10. 2018.